PERIPHERAL NEUROPATHIES Biomarkers for axonal damage in immune-mediated neuropathy

B.C. Jacobs; HJ Willison

doi:10.1038/nrneurol.2009.161

PERIPHERAL NEUROPATHIES Biomarkers for axonal damage in immune-mediated neuropathy

B.C. Jacobs, HJ Willison

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Abstract

Biomarkers are generally used as diagnostic and prognostic tools in clinical practice, but are not yet available for neuropathies. Studies now suggest that neural protein levels in serum and cerebrospinal fluid reflect axonal damage and predict poor outcome in patients with immune-mediated neuropathy, although validation studies are needed to define their clinical relevance.

Original language	Undefined/Unknown
Pages (from-to)	584-585
Number of pages	2
Journal	Nature Reviews Neurology
Volume	5
Issue number	11
DOIs	https://doi.org/10.1038/nrneurol.2009.161
Publication status	Published - 2009

Research programs

EMC MM-02-72-02
EMC MM-04-44-02

Access to Document

10.1038/nrneurol.2009.161

http://hdl.handle.net/1765/24589

Cite this

@article{c9d5b505d9124f49801e4cd6281497c0,

title = "PERIPHERAL NEUROPATHIES Biomarkers for axonal damage in immune-mediated neuropathy",

abstract = "Biomarkers are generally used as diagnostic and prognostic tools in clinical practice, but are not yet available for neuropathies. Studies now suggest that neural protein levels in serum and cerebrospinal fluid reflect axonal damage and predict poor outcome in patients with immune-mediated neuropathy, although validation studies are needed to define their clinical relevance.",

author = "B.C. Jacobs and HJ Willison",

year = "2009",

doi = "10.1038/nrneurol.2009.161",

language = "Undefined/Unknown",

volume = "5",

pages = "584--585",

journal = "Nature Reviews Neurology",

issn = "1759-4758",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - PERIPHERAL NEUROPATHIES Biomarkers for axonal damage in immune-mediated neuropathy

AU - Jacobs, B.C.

AU - Willison, HJ

PY - 2009

Y1 - 2009

N2 - Biomarkers are generally used as diagnostic and prognostic tools in clinical practice, but are not yet available for neuropathies. Studies now suggest that neural protein levels in serum and cerebrospinal fluid reflect axonal damage and predict poor outcome in patients with immune-mediated neuropathy, although validation studies are needed to define their clinical relevance.

AB - Biomarkers are generally used as diagnostic and prognostic tools in clinical practice, but are not yet available for neuropathies. Studies now suggest that neural protein levels in serum and cerebrospinal fluid reflect axonal damage and predict poor outcome in patients with immune-mediated neuropathy, although validation studies are needed to define their clinical relevance.

U2 - 10.1038/nrneurol.2009.161

DO - 10.1038/nrneurol.2009.161

M3 - Article

SN - 1759-4758

VL - 5

SP - 584

EP - 585

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

IS - 11

ER -